{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-114448","form_type":"8-K","ticker":"SEM","cik":"0001320414","company_name":"SELECT MEDICAL HOLDINGS CORP","filed_at":"2022-11-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:50.120143+00:00","generated_at":"2026-06-22T08:18:21.576880+00:00","sec_items":["2.02","8.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Select Medical Q3 net income drops 62% to $38.1M; EPS $0.21 vs $0.57","bullets":["Revenue $1,567.8M (+2.2% YoY); net income $38.1M vs $100.2M; EPS $0.21 vs $0.57.","Adjusted EBITDA fell to $153.1M from $208.6M; operating income $91.5M vs $150.3M.","Critical illness recovery hospital segment Adjusted EBITDA plunged to $11.0M from $57.2M; margin 2.1% vs 10.8%.","Board declared $0.125 per share dividend, payable Nov 29 to holders of record Nov 16.","Reaffirmed FY2022 revenue outlook of $6.25-6.40B; labor climate delays EBITDA and EPS guidance."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-114448","json":"https://secwatch.observer/filing/0001104659-22-114448.json","markdown":"https://secwatch.observer/filing/0001104659-22-114448.md","text":"https://secwatch.observer/filing/0001104659-22-114448.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1320414/000110465922114448/0001104659-22-114448-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1320414/000110465922114448/tm2229569d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T08:18:21.576880+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1dd7b83f21449213616049399de6417671bded6f","claim":"SELECT MEDICAL HOLDINGS CORP reported nine months ended September 30, 2022 results: revenue $4,752.1 million, net income $160.3 million, EPS $1.01.","evidence_excerpt":"For the nine months ended September 30, 2022, revenue increased 2.3% to $4,752.1 million, compared to $4,644.7 million for the same period, prior year.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1320414/000110465922114448/0001104659-22-114448-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"nine months ended September 30, 2022"},{"label":"Revenue","value":"$4,752.1 million"},{"label":"Net income","value":"$160.3 million"},{"label":"EPS","value":"$1.01"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"c6ad90d514e267f72a9f4e86414ac36af8dcbc10","claim":"SELECT MEDICAL HOLDINGS CORP reported third quarter ended September 30, 2022 results: revenue $1,567.8 million, net income $38.1 million, EPS $0.21.","evidence_excerpt":"Select Medical Holdings Corporation (“Select Medical,” “we,” “us,” or “our”) (NYSE: SEM) today announced results for its third quarter ended September 30, 2022, and the declaration of a cash dividend. For the third quarter ended September 30, 2022, revenue increased 2.2% to $1,567.8 million, compared to $1,534.2 million for the same quarter, prior year.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1320414/000110465922114448/0001104659-22-114448-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"third quarter ended September 30, 2022"},{"label":"Revenue","value":"$1,567.8 million"},{"label":"Net income","value":"$38.1 million"},{"label":"EPS","value":"$0.21"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}